KELLI KING: Open Payments
NPI 1841357076 · NORTH PLATTE, NE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$499 in 11 payments from 5 companies in 2025. Trend: 2023 $457 · 2024 $496 · 2025 $499
Food & beverage: $499
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 6 | $309 |
| ABBVIE INC. | 1 | $122 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 2 | $40 |
| Xeris Pharmaceuticals, Inc. | 1 | $16 |
| BioWound Solutions, Inc. | 1 | $11 |
Products named: BREZTRI, QULIPTA, FASENRA, FARXIGA, CAPLYTA, GVOKE HYPOPEN, bio-ConneKt.
Industry payments across NE — which companies pay providers there.
